Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
Frequently Asked Questions / Types of Cancer / OncoLink Vet / Veterinary Oncology
Last Modified: October 8, 2006
![]()
Dear OncoLink "Ask The Experts,"
My four-year-old black lab had her left kidney removed due to an abnormality on ultrasound, and at the time of surgery, a 3 cm tumor was found with pathology revealing a renal papillary adenocarcinoma. Radiographs were taken prior to surgery showing no apparent spread of the cancer, and she has showed 100% improvement, but they are recommending chemotherapy. I have not been able to find a lot of info about kidney cancer in dogs, and what I have found does not make chemotherapy sound very promising, so we are hesitant.
![]()
Lili Duda, VMD, Section Editor of the OncoLink Veterinary Oncology Menu, responds:
Renal (kidney) tumors are rare in dogs. The typical dog is middle-aged to older, and there is no breed or sex predilection. The exception is the German Shepard, which is predisposed to a syndrome of renal cystadenocarcinomas and nodular dermatofibrosis. The majority of primary renal tumors are carcinomas, but a variety of other types have been reported. In addition, some types of cancers can metastasize (spread) to the kidney from other locations.
Some dogs have no clinical signs associated with a kidney tumor. Others might have symptoms associated with the urinary tract, such as bloody urine or frequent urination. If the cancer has metastasized, which occurs in about half of dogs with renal carcinoma, there can be symptoms related to the organ or tissue that is involved.
A thorough staging evaluation is always indicated when a kidney tumor is detected. This includes chest radiographs (X-rays), abdominal ultrasound, and complete blood cell count and chemistry profile. The most common sites of spread are the lung, liver, and the linings of the abdominal cavity.
If there is no detectable evidence of cancer spread to other sites, if the uninvolved kidney has good function, and if the dog is in good enough health to tolerate surgery, then nephrectomy (removal of the affected kidney) is usually indicated. However, metastasis might still become evident weeks or months following surgery. Unfortunately, there is little evidence to indicate what type of chemotherapy might be effective in delaying or preventing this occurrence. In humans, this type of cancer tends to be resistant to chemotherapy.
Dr. Lin discusses head and neck cancer treatment, the potential side effects and the importance of being prepared and treated for them. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

